Education about complementary and alternative medicine in cancer self-help groups by trained peers.
Complementary and alternative medicine
Health literacy
Oncology
Patient information
Self-help group
Journal
BMC complementary medicine and therapies
ISSN: 2662-7671
Titre abrégé: BMC Complement Med Ther
Pays: England
ID NLM: 101761232
Informations de publication
Date de publication:
19 Oct 2024
19 Oct 2024
Historique:
received:
26
03
2024
accepted:
11
10
2024
medline:
20
10
2024
pubmed:
20
10
2024
entrez:
19
10
2024
Statut:
epublish
Résumé
On average, about 50% of cancer patients use complementary and alternative medicine (CAM) in addition to conventional cancer treatment. Since there is a high need for information, patients often search for information about CAM and share experiences with peers, especially in self-help groups. In this study, we tested and evaluated an educational concept developed for group leaders of cancer self-help groups on how to approach the topic of CAM in their peer groups. The educational concept has been developed and piloted with health care professionals and representatives from different self-help organizations in Germany. It aims to inform and discuss the possibilities and limitations of CAM in terms of scientific evidence, to reflect user behavior, and to provide a guide on how to find and evaluate reliable and evidence-based information sources. First, self-help group leaders took part in an on-site training where they were educated on various CAM topics with the goal of being able to conduct the educational concept in their respective self-help groups. Then, the educated group leaders performed this concept in their groups. The educational concept was evaluated by both the group leaders and participants with respect to acceptance, usefulness, and satisfaction using paper-pencil questionnaires. The study was conducted in Germany based on an observational study design with a six-month follow-up. For the analyses, descriptive and univariate statistics for dependent samples were used. A total of n = 50 interested group leaders conducted the educational program in their groups. The most common implementation barriers were organizational or structural problems, as well as the feeling of being overwhelmed with managing the program in their groups. A total of n = 423 participants were educated with this program by their respective group leaders. The majority felt satisfied with the educational program and improved their knowledge about CAM. At the six months follow-up (T2), significantly more participants had consulted their physicians to inform themselves about CAM and felt more confident in finding reliable information about CAM. In this observational study, we have managed to successfully implement an educational concept with respect to the topic of CAM in cancer self-help groups. Based on the results, the concept approach will be modified to include both a CAM- professional and group leader to train the self-help groups. In the future, the effects of the program should be tested by a randomized trial.
Identifiants
pubmed: 39427169
doi: 10.1186/s12906-024-04680-2
pii: 10.1186/s12906-024-04680-2
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
373Informations de copyright
© 2024. The Author(s).
Références
Fremd C, Hack CC, Schneeweiss A, et al. Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study network. Arch Gynecol Obstet. 2017;295:1239–45.
doi: 10.1007/s00404-017-4348-2
pubmed: 28331996
Qureshi M, Zelinski E, Carlson LE. Cancer and complementary therapies: current trends in survivors’ interest and use. Integr Cancer Ther. 2018;17:844–53.
doi: 10.1177/1534735418762496
pubmed: 29629606
pmcid: 6142098
Horneber M, Bueschel G, Dennert G, et al. How many Cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther. 2012;11:187–203.
doi: 10.1177/1534735411423920
pubmed: 22019489
Nilsson J, Källman M, Östlund U, et al. The Use of complementary and alternative medicine in Scandinavia. Anticancer Res. 2016;36:3243–51.
pubmed: 27354580
Akpunar D, Bebis H, Yavan T. Use of complementary and alternative medicine in patients with Gynecologic Cancer: a systematic review. Asian Pac J Cancer Prev APJCP. 2015;16:7847–52.
doi: 10.7314/APJCP.2015.16.17.7847
pubmed: 26625809
Witt CM, Balneaves LG, Cardoso MJ et al. A Comprehensive Definition for Integrative Oncology. J Natl Cancer Inst Monogr. 2017, 1;2017(52). https://doi.org/10.1093/jncimonographs/lgx012 . PMID: 29140493.
Scarton LA, Del Fiol G, Oakley-Girvan I, et al. Understanding cancer survivors’ information needs and information-seeking behaviors for complementary and alternative medicine from short- to long-term survival: a mixed-methods study. J Med Libr Assoc JMLA. 2018;106:87–97.
pubmed: 29339938
Campo RA, Leniek KL, Gaylord-Scott N, et al. Weathering the Seasons of Cancer Survivorship: mind-body therapy use and reported reasons and outcomes by stages of Cancer Survivorship. Support Care Cancer. 2016;24:3783–91.
doi: 10.1007/s00520-016-3200-8
pubmed: 27048456
pmcid: 4967379
Caughey L, Sanjida S, Obermair A et al. The use of CAM products, practices, and practitioners by long-term endometrial cancer survivors in Australia. Support Care Cancer 2020 28, 5479–89. https://doi.org/10.1007/s00520-020-05404-1
Keene MR, Heslop IM, Sabesan SS, et al. Complementary and alternative medicine use in cancer: a systematic review. Complement Ther Clin Pract. 2019;35:33–47. https://doi.org/10.1016/j.ctcp.2019.01.004 .
doi: 10.1016/j.ctcp.2019.01.004
pubmed: 31003679
Pihlak R, Liivand R, Trelin O, et al. Complementary medicine use among cancer patients receiving radiotherapy and chemotherapy: methods, sources of information and the need for counselling. Eur J Cancer Care. 2014;23:249–54.
doi: 10.1111/ecc.12132
Latte-Naor S, Sidlow R, Sun L, et al. Influence of family on expected benefits of complementary and alternative medicine (CAM) in cancer patients. Support Care Cancer. 2018;26:2063–9.
doi: 10.1007/s00520-018-4053-0
pubmed: 29368030
pmcid: 6387788
AWMF. S3-Leitlinie: Komplementärmedizin in der Behandlung von onkologischen PatientInnen. Leitlinien-Detailansicht. 2021. https://www.awmf.org/leitlinien/detail/ll/032-055OL.html
Hübner J, Beckmann M, Follmann M et al. Complementary Medicine in the Treatment of Cancer Patients. Dtsch Arztebl Int. 2021, 1;118(39):654–659. https://doi.org/10.3238/arztebl.m2021.0277
Kutschan S, Freuding M, Keinki C, et al. Recommendations on complementary and alternative medicine within S3 guidelines in oncology: systematic quality assessment of underlying methodology. J Cancer Res Clin Oncol. 2020;146:2419–25.
doi: 10.1007/s00432-020-03238-2
pubmed: 32394053
pmcid: 7382657
Veziari Y, Leach MJ, Kumar S. Barriers to the conduct and application of research in complementary and alternative medicine: a systematic review. BMC Complement Altern Med 2017, 23;17(1):166. https://doi.org/10.1186/s12906-017-1660-0
Mazzocut M, Truccolo I, Antonini M, et al. Web conversations about complementary and alternative Medicines and Cancer: content and sentiment analysis. J Med Internet Res. 2016;16(6):e120. https://doi.org/10.2196/jmir.5521 .
doi: 10.2196/jmir.5521
Weis J, Gschwendtner K, Güthlin C, et al. Utilisation of complementary medicine in cancer patients and survivors: expected benefits and its association to psychosocial factors. Europ J Cancer Care. 2022;31(6):e13690. https://doi.org/10.1111/ecc.13690 .
doi: 10.1111/ecc.13690
Hack CC, Wasner S, Meyer J et al. Analysis of oncological second opinions in a Certified University breast and Gynecological Cancer Center in Relation to complementary and alternative medicine. Complement Med Res. 2020;1–9.
Kessel KA, Klein E, Hack CC, et al. Complementary medicine in radiation oncology. Strahlenther Onkol. 2018 Oct;194(10):904–10. https://doi.org/10.1007/s00066-018-1345-8 .
Simpson E, Forster K, McMillan S, et al. The impact of an evidence-based education on complementary and alternative medicine usage in people with Cancer: pilot study. J Cancer Educ. 2021;36(5):1061–8. https://doi.org/10.1007/s13187-020-01734-0 .
doi: 10.1007/s13187-020-01734-0
pubmed: 32170577
Ameenat A, Akeeb SM, King O, Olaku, et al. Communication between Cancer patients and Physicians about complementary and alternative medicine: a systematic review. J Integr Complement Med. 2023;80–98. https://doi.org/10.1089/jicm.2022.0516 .
Horneber M, van Ackeren G, Fischer F, et al. Addressing Unmet Information needs: results of a clinician-led Consultation Service about complementary and alternative medicine for Cancer patients and their relatives. Integr Cancer Ther. 2018;17(4):1172–82. https://doi.org/10.1177/1534735418808597 .
doi: 10.1177/1534735418808597
pubmed: 30352519
pmcid: 6247549
Witt CM, Helmer SM, Schofield P, et al. Training oncology physicians to advise their patients on complementary and integrative medicine: an implementation study for a manual-guided consultation. Cancer. 2020;126:3031–41.
doi: 10.1002/cncr.32823
pubmed: 32286693
Stub T, Quandt SA, Arcury TA, et al. Perception of risk and communication among conventional and complementary health care providers involving cancer patients’ use of complementary therapies: a literature review. BMC Complement Altern Med. 2016;16:353.
doi: 10.1186/s12906-016-1326-3
pubmed: 27609097
pmcid: 5016861
Smith PJ, Clavarino AM, Long JE, et al. The Use of a brochure to Enable CAM-with-chemotherapy patient education. J Cancer Educ. 2017;32:814–9.
doi: 10.1007/s13187-016-1011-8
pubmed: 26932309
Thakerar A, Sanders J, Moloney M, et al. Pharmacist advice on the safety of complementary and alternative Medicines during conventional anticancer treatment. J Pharm Pract Res. 2014;44:231–7.
doi: 10.1002/jppr.1031
Ziemann J, Lendeckel A, Müller S, et al. Herb-drug interactions: a novel algorithm-assisted information system for pharmacokinetic drug interactions with herbal supplements in cancer treatment. Eur J Clin Pharmacol. 2019;75:1237–48. https://doi.org/10.1007/s00228-019-02700-6 .
doi: 10.1007/s00228-019-02700-6
pubmed: 31154477
Roter DL, Yost KJ, O’Byrne T, et al. Communication predictors and consequences of complementary and alternative medicine (CAM) discussions in oncology visits. Patient Educ Couns. 2016;99:1519–25.
doi: 10.1016/j.pec.2016.06.002
pubmed: 27296081
pmcid: 5007180
Sohl SJ, Borowski LA, Kent EE, et al. Cancer survivors’ disclosure of complementary health approaches to physicians: the role of patient-centered communication. Cancer. 2015;121:900–7.
doi: 10.1002/cncr.29138
pubmed: 25387799
Dişsiz G, Yilmaz M. Complementary and alternative therapies and health literacy in cancer patients. Complement Ther Clin Pract. 2016;23:34–9.
doi: 10.1016/j.ctcp.2016.02.004
pubmed: 27157956
Allen Searson N, Balneaves LG, Thorne SE, et al. The Effect of a complementary Therapy Education Seminar on Support persons of individuals with Cancer. J Altern Complement Med. 2021;27(4):365–72. https://doi.org/10.1089/acm.2020.0443 . https://www.liebertpub.com/doi/ .
doi: 10.1089/acm.2020.0443
pubmed: 33601933
Bozza C, Gerratana L, Basile D, et al. Use and perception of complementary and alternative medicine among cancer patients: the CAMEO-PRO study. J Cancer Res Clin Oncol. 2018;144:2029–47.
doi: 10.1007/s00432-018-2709-2
pubmed: 30043280
Verhoef MJ, Trojan L, Armitage GD, et al. Complementary therapies for cancer patients: assessing information use and needs. Chronic Dis Can. 2009;29:80–8.
doi: 10.24095/hpcdp.29.2.06
pubmed: 19281693
Ziegler E, Hill J, Lieske B, et al. Empowerment in cancer patients: does peer support make a difference? A systematic review. Psychooncology. 2022;31:683–704. https://doi.org/10.1002/pon.5869 .
doi: 10.1002/pon.5869
pubmed: 34981594
Witt CM, Bartsch H-H, Güthlin C, et al. Kompetenznetz Komplementärmedizin in Der Onkologie (KOKON): Ein Wissenschaftlicher Beitrag Zur Verbesserung Der Versorgung. Forum. 2017;32:416–23.
doi: 10.1007/s12312-017-0311-1
Güthlin C, Bartsch H-H, Joos S, et al. KOKON: A Germany-wide collaborative Research Project to identify needs, provide information, Foster Communication and Support decision-making about complementary and alternative medicine in Oncology. Complement Med Res. 2020;27:105–11.
doi: 10.1159/000502945
pubmed: 31722354
Jablotschkin M, Bartsch HH, Gschwendtner K et al. Educational Program in complementary and alternative medicine for Cancer Self-Help groups. Complement Med Res. 2019;1–8.
Haus der Krebs-Selbsthilfe Bundesverband e. V. Haus der Krebs-Selbsthilfe Bundesverband e.V. Organisation. 2021. https://www.hausderkrebsselbsthilfe.de/wir-ueber-uns/organisation/
Deutsches Krebsforschungszentrum. Krebsinformationsdienst. Altern. Komplementäre Methoden Krebstherapie Ein Überblick [Alternative complementary methods in cancer therapy: an overview]. 2018. https://www.krebsinformationsdienst.de/behandlung/unkonv-methoden/index.php
Kompetenznetz für Komplementärmedizin in der Onkologie. KOKON. KOKONinfo. 2016. https://www.kokoninfo.de/
Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie e.V. Onkopedia. Komplementäre Alternative Therapie [complementary alternative therapy]. 2020. https://www.onkopedia.com/de/onkopedia/guidelines
Memorial Sloan Kettering Cancer Center. Search about herbs. Integr. Med. Search Herbs. 2020. https://www.mskcc.org/cancer-care/diagnosis-treatment/symptom-management/integrative-medicine/herbs/search